NEW YORK, NY (Marketwired – Jul 8, 2014)
With all eyes on the 2014 World Cup, the Copenhagen Centre for Team Sport and Health recently published a study featuring the positive impact of playing soccer while undergoing hormone therapy for prostate cancer. The results highlight the benefits of physical activity for prostate cancer patients, showing greater muscle mass and improved functional capacity, as well an increase in positive social experiences and the desire to be active.
Hormone therapy is a prostate cancer treatment option most often elected by men with advanced disease that has spread beyond the prostate. Robotic prostate surgeon, David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, recently spoke on air about the challenges associated with hormone therapy.
“Hormone therapy is best reserved for men who are not surgical candidates,” said Dr. Samadi. “Reducing testosterone levels causes male menopause which can lead to heart disease, increased cholesterol, and an increased risk of heart attack. It opens the door to side effects than can significantly alter a man’s quality of life.”
Hormone therapy, commonly given under the brand names Lupron and Zoladex, is used to reduce or suspend the body’s natural production of testosterone and ultimately starve the prostate tumor. Side effects of hormone therapy for prostate cancer can include low sex drive, hot flashes, and reduced bone density.
“Many prostate cancer patients are still quite young and are not prepared for the physical changes that come with hormone therapy, particularly loss of libido and sexual potency,” said Dr. Samadi. “Loss of bone density can pose a significant threat and can greatly increase a man’s risk of bone fracture, as well.”
“When prostate cancer is confined to the prostate, robotic prostatectomy is the preferred treatment.”Press Release